A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I–Converting Enzyme Inhibitors
- 1 October 2005
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 77 (4), 617-626
- https://doi.org/10.1086/496899
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJournal of Allergy and Clinical Immunology, 2004
- Insights into the physiological role of WT1 from studies of genetically modified micePhysiological Genomics, 2004
- Trans-acting regulatory variation in Saccharomyces cerevisiae and the role of transcription factorsNature Genetics, 2003
- Omapatrilat- the story of Overture and OctaveInternational Journal of Cardiology, 2002
- Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-BradykininJournal of Pharmacology and Experimental Therapeutics, 2002
- Preliminary survey of the occurrence of anaphylactoid reactions during haemodialysisNephrology Dialysis Transplantation, 1999
- Assignment of the Membrane-Bound Human Aminopeptidase P Gene (XPNPEP2) to Chromosome Xq25Genomics, 1998
- Multipoint Quantitative-Trait Linkage Analysis in General PedigreesAmerican Journal of Human Genetics, 1998
- ACE Inhibitor???Induced AngioedemaDrug Safety, 1998
- Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.Hypertension, 1992